XOMA Royalty (XOMA) Return on Sales Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) Return on Sales Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 0.00 |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 20.00 |
| Jun 30, 2025 | 3.00 |
| Mar 31, 2025 | 8.00 |
| Dec 31, 2024 | -3.00 |
| Sep 30, 2024 | 54.00 |
| Jun 30, 2024 | 5.00 |
| Mar 31, 2024 | 18.00 |
| Dec 31, 2023 | -8.00 |
| Sep 30, 2023 | -23.00 |
| Jun 30, 2023 | 29.00 |
| Mar 31, 2023 | -25.00 |
| Dec 31, 2022 | -157.00 |
| Sep 30, 2022 | -24.00 |
| Jun 30, 2022 | -37.00 |
| Mar 31, 2022 | 19.00 |
| Dec 31, 2021 | 148.00 |
| Sep 30, 2021 | -6.00 |
| Jun 30, 2021 | 64.00 |
| Mar 31, 2021 | -10.00 |